O conteúdo desse portal pode ser acessível em Libras usando o VLibras


Oswaldo Cruz Foundation an institution in the service of life

Início do conteúdo

Buscar na Fiocruz

Exibindo 25 de 849 resultados encontrados
Opções avançadas
Data de publicação: 30/11/2022 - 16:27
Fiocruz attended the 150 years of Oswaldo Cruz and 200 years of Louis Pasteur symposium, organized by the National Academy of Medicine (ANM, in the French acronym). Fiocruz president, Nísia Trindade Lima; the vice-president of Research, Innovation and Production in Health (VPPIS/Fiocruz), Marco Krieger, and Cláudio Tadeu Daniel-Ribeiro, scholar and researcher of the Oswaldo Cruz Institute (IOC/Fiocruz), represented the Foundation...
Data de publicação: 30/11/2022 - 15:10
The Pasteur Network Annual Meeting 2022 was held this Monday and Tuesday (11/28 and 29), bringing together representatives of the scientific community linked to the network around the world to discuss challenges and paths for public health. The meeting took place in Rome, Italy, and had the participation of Fiocruz representatives. Among them, the professor and researcher Wilson Savino, who moderated the plenary session 2, about “...
Data de publicação: 29/11/2022 - 15:34
Between 7 and 19 December, Montreal, Canada, will be hosting the 15th Conference of the Parties (COP15) of the United Nations Convention on Biological Diversity (CDB), known as the Biodiversity Summit. Researchers Manuela da Silva, Márcia Chame, Marcelo Pelajo and Guilherme Franco Netto will be part of the Brazilian delegation, representing Fiocruz. Marcia Chame is coordinator of the Institutional Platform for Biodiversity and Wildlife...
Data de publicação: 11/10/2022 - 10:10
The fungus that causes histoplasmosis, a disease that can affect the lungs and lead to death, was detected in Antarctica for the first time, as revealed by the study Molecular Detection of Histoplasma capsulatum in Antarctica. Written by Fioantar researchers, the paper is part of the October issue of the Emerging Infectious Diseases Journal, published by the Centers for Disease Control and Prevention (CDC) of the United States, and is one of the...
Data de publicação: 25/11/2022 - 16:27
Researchers of the Laboratory of Entomology Diversity of the Oswaldo Cruz Institute (IOC/Fiocruz) identified a new species of stick insect in Petrópolis, in the mountainous region of the state of Rio de Janeiro. It has been named Cladomorphus petropolisensis, after the city where it was collected. The finding was published in the 10-year anniversary issue of Animals. The last species of genus Cladomorphus in the region was described in...
Data de publicação: 29/11/2022 - 12:22
On November 23rd, Fiocruz and Servier Institute signed a memorandum of understanding that establishes the foundations for technical cooperation in order to hold the second edition of the International Fiocruz/Servier Award, the first of its kind in the field of oncology. Overall, €150,000 will be going to three innovative research projects that focus on cancer treatment. The announcement is expected to be launched by the end of January 2023...
Data de publicação: 18/11/2022 - 12:36
Last Saturday (November 12) the Fiocruz Genomic Network announced the appearance of a new Omicron variant in the state of Amazonas. The variant seems to be responsible for the recent increase in the number of cases in the state. According to researcherTiago Gräf, of the Genomic Network, Amazonas has been a sentinel territory for COVID-19 monitoring. “What happens in the state tends to also happen in other regions, and it may be...
Data de publicação: 10/10/2022 - 16:55
SpiN-TEC, a COVID-19 vaccine developed by Fiocruz Minas and by the Federal University of Minas Gerais (UFMG), can begin to be tested in humans. Last Monday (October 3), the Brazilian Health Surveillance Agency (Anvisa) authorized the beginning of the so-called clinical trials. From now on, researchers can move on to the step that evaluates the safety and the immune response generated by the vaccine. In this new phase, the immunizer will be...
Data de publicação: 22/11/2022 - 12:43
Restrictions to the distribution of biological material placed by the legislation of countries such as India, South Africa and Brazil do not include lineages intended to be used as type lineage, i.e. material for the validation or valid publication of names of species of bacteria. This issue is the central theme of the paper entitled How legislations affect new taxonomic descriptions, published on Trends in Microbiology in November. The...
Data de publicação: 21/11/2022 - 09:47
A scientific paper written by researchers of the BR COVID-19 Observatory, with the participation of scientists from Unesp, Fiocruz, Unicamp, UFABC and USP, presents a thorough statistical analysis to measure, in figures, the fundamental role played by mass vaccination against COVID-19 and the efficacy of this sanitary strategy implemented amidst much misinformation and hesitancy during the sanitary crisis installed in Brazil. The analysis...
Data de publicação: 25/11/2022 - 15:48
A survey by the World Health Organization (WHO) has placed Fiocruz among the world’s 15 main vaccine manufacturers. The 2022 Global Vaccine Market Report gives information on the dynamics of the vaccines market, based on the data provided by the WHO Member States. Subtitled A shared understanding for equitable access to vaccines, the report “aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more...
Data de publicação: 06/10/2022 - 11:07
In people who received two doses of the inactivated Coronavac vaccine, an mRNA boost offers considerably better protection against mild and severe COVID-19 than a boost with the same vaccine, according to a large observational study performed in Brazil and co-led by Fiocruz and the Barcelona Institute for Global Health (ISGlobal), an institution supported by “La Caixa” Foundation. These findings, published in Nature Communications,...
Data de publicação: 03/10/2022 - 16:11
By means of its Center for Technological Development in Health (CDTS), Fiocruz is now part of  Repurposing of Medicines 4ALL – REMEDI4ALL, a project financed by the European Commission with the goal of supporting medicines repurposing. Initially conceived to work for five years and with a budget of 25 million euros, the platform is made up of 26 institutions from all over the world, including hospitals, research institutions,...
Data de publicação: 17/11/2022 - 13:52
The Fiocruz president, Nísia Trindade Lima, and researchers Lucia Souto, Maria do Socorro de Souza and José Gomes Temporão were appointed, this Wednesday (November 16th), to the Health Technical Group in the transition team of the elected President of the Republic, Luiz Inácio Lula da Silva. The announcement was made by the vice-president-elect and coordinator of the government transition, Geraldo Alckmin, at the...
Data de publicação: 22/11/2022 - 14:50
In an article published last week in the scientific journal The Lancet, experts from different countries, such as Brazil, South Africa and the United States, draw attention to the inequities faced in the COVID-19 pandemic with regard to human rights at national and global levels. In an analysis of these inequalities, pointing out differences in access to vaccination and medication, for example, the authors propose alternatives for a new story in...
Data de publicação: 28/09/2022 - 16:09
In a recent qualification course on the diagnosis of tegumentary leishmaniasis and patient care, health workers from Belize, a country in the East coast of Central America, were trained in Porto Velho. Attendants were able to follow, in practical terms, all phases of the care provided to previously scheduled patients, from reception and medical consultation at the dermatology clinic of the Rondônia Center for Tropical Medicine (Cemetron)...
Data de publicação: 16/11/2022 - 15:13
An article published in Nature magazine includes a list of 57 recommendations with a high degree of consensus amongst experts to end the threat to public health represented by COVID-19. The work was drawn up by a panel consisting of 386 scientists from 112 countries. Led by the Barcelona Global Health Institute (ISGlobal), the study boasts the participation of ten Brazilian scientists, of which five are from Fiocruz (Mauricio Barreto, Tania...
Data de publicação: 26/09/2022 - 11:04
Social and environmental determinants of health are the main investigation subject of a vast research program led by the Centre for Data and Knowledge Integration for Health (Cidacs/Fiocruz Bahia) together with researchers from Brazil, the United Kingdom, and Ecuador. Brazilian and European investigators had already been dedicated to studies that evaluate the impacts of public policies on social inequalities in health in Brazil since 2017,...
Data de publicação: 23/09/2022 - 15:58
Between January and August 2019, sixteen indigenous children died in Alto do Rio Purus, in the state of Acre. The youngest was only a one-month-old baby. All died of diarrhea. These cases are worthy of notice and science show that it is not a temporary crisis. We are talking about a chronic condition caused by the living and health conditions of indigenous children in Brazil. According to an article published in the October issue of The Lancet...
Data de publicação: 08/11/2022 - 12:13
The United States Agency for International Development (USAID), the New Partnerships Initiative, Expanding Health Partnerships (NPI EXPAND), SITAWI (Finance for Good) and the Leônidas & Maria Deane Institute (ILMD/Fiocruz Amazônia) partnered to support the Response to COVID-19 in the Brazilian Amazon Region. The Response to COVID-19 in the Brazilian Amazon - Phase 2 is an initiative that involves civil society organizations in...
Data de publicação: 31/10/2022 - 16:42
The Fiocruz Observa Infância made a survey on infant malnutrition which showed that the rates for babies below one year old have been rising in Brazil. Data show that in 2021 the Unified Health System (SUS, the Brazilian public health system) recorded an average of eight infant hospitalizations per day due to malnutrition, a consequence of nutritional deficiencies in this age group. There were a total of 2,979 hospitalizations for this age...
Data de publicação: 23/09/2022 - 11:18
Through its Institute of Technology in Immunobiologicals (Bio-Manguinhos), Fiocruz was granted by the Brazilian Health Regulatory Agency, last Tuesday (20 September) the definitive registration for the OPXV/MPXV/VZV/RP Multiplex Molecular Kit for the diagnosis of monkeypox and other diseases with similar symptoms, in a differential manner. The Institute, therefore, becomes the holder of the first registration of a diagnostic product for the...
Data de publicação: 31/10/2022 - 15:28
An unpublished study led by Fiocruz Amazônia evaluated the excess maternal deaths in Brazil during the first 15 months of the COVID-19 pandemic. Epidemiologist Jesem Orellana, of the Leônidas and Maria Deane Institute (ILMD/Fiocruz Amazônia), together with researchers from Brazilian, Colombian and North-American universities, showed the very worrying increase in maternal deaths in Brazil, especially during the trimester from...
Data de publicação: 22/09/2022 - 13:19
Over the last century, poliomyelitis affected hundreds of thousands of people, causing irreversible paralysis and claiming lives. Global vaccination efforts against this infectious and contagious disease, however, managed to drastically reduce its dissemination and impact. These efforts are currently being put to the test by recent challenges such as the Covid-19 pandemic, natural disasters, and armed conflicts, in addition to vaccine hesitation...
Data de publicação: 31/10/2022 - 13:51
Last Monday (24 October), Nísia Trindade Lima, president of Fiocruz, was granted the official certificate of the 2022 Brazilian Women Making a Difference Award. The award is granted by the US embassy and consulates in Brazil, as acknowledgement to relevant women all over the country. The certificate was handed to Lima by Mark Carr, cultural attaché of the United States Consulate in Rio de Janeiro, who visited the Foundation in the...


Back to the topBack